Need professional-grade analysis? Visit stockanalysis.com
$630,018
N/A
N/A
N/A
StageZero Life Sciences Ltd (SZLSF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.01.
Over the past year, SZLSF has traded between a low of $0.00 and a high of $0.03. The stock has gained 70.0% over this period. It is currently 83.3% below its 52-week high.
StageZero Life Sciences Ltd has a market capitalization of $630,018.
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer detection panel that tests blood for multiple discrete cancer. It also offers ColonSentry, a blood-based test to determine an individual's current risk for having colorectal cancer. The company is based in Richmond Hill, Canada.
Side-by-side comparison against top Healthcare peers.